Evaluation of response to immune checkpoint inhibitors: Is there a role for positron emission tomography?

about

The new era of cancer immunotherapy: what can molecular imaging do to help?Immune-related tumor response assessment criteria: a comprehensive review.

P2860

Q47308572-198EF35E-BD84-4F49-8BC2-E98207D32F9D Q49668388-315F34CF-3AB0-4A6C-BCC2-08DFD9FA512C

P2860

Evaluation of response to immune checkpoint inhibitors: Is there a role for positron emission tomography?

Item

http://www.wikidata.org/entity/Q42318752

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Evaluation of response to immu ...... positron emission tomography?

@en

Evaluation of response to immu ...... positron emission tomography?

@nl

type

Item

label

Evaluation of response to immu ...... positron emission tomography?

@en

Evaluation of response to immu ...... positron emission tomography?

@nl

prefLabel

Evaluation of response to immu ...... positron emission tomography?

@en

Evaluation of response to immu ...... positron emission tomography?

@nl

P1476

Evaluation of response to immu ...... positron emission tomography?

@en

P2093

Francesco Grossi

http://www.w3.org/2001/XMLSchema#string

Gianmario Sambuceti

http://www.w3.org/2001/XMLSchema#string

Matteo Bauckneht

http://www.w3.org/2001/XMLSchema#string

Roberta Piva

http://www.w3.org/2001/XMLSchema#string

Silvia Morbelli

http://www.w3.org/2001/XMLSchema#string

P2860

The PD-1 pathway in tolerance and autoimmunity

Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

High-Resolution PET Imaging with Therapeutic Antibody-based PD-1/PD-L1 Checkpoint Tracers

The blockade of immune checkpoints in cancer immunotherapy

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

CTLA-4 can function as a negative regulator of T cell activation

Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group.

64Cu-DOTA-anti-CTLA-4 mAb enabled PET visualization of CTLA-4 on the T-cell infiltrating tumor tissues

P304

27-33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.4329/WJR.V9.I2.27

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28298962

http://www.w3.org/2001/XMLSchema#string

P932

5334499

http://www.w3.org/2001/XMLSchema#string

Evaluation of response to immune checkpoint inhibitors: Is there a role for positron emission tomography?

about

P2860

P2860

Evaluation of response to immune checkpoint inhibitors: Is there a role for positron emission tomography?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932